ClinicalMetric / Countries / Japan / perianal crohn s disease
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

perianal crohn s disease Clinical Trials in Japan

Active clinical trials for perianal crohn s disease with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 4 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT07872449 Phase 4
Recruiting

Risankizumab for Refractory Perianal Fistulizing Crohn's Disease

Enrollment
25 pts
Country
🇯🇵 Japan
Yuki Horio
View Trial →

Frequently Asked Questions

How many perianal crohn s disease clinical trials are active in Japan?
There are currently 1 active clinical trials for perianal crohn s disease with sites in Japan, of which 1 are actively recruiting patients.
How can I join a perianal crohn s disease clinical trial in Japan?
To join a perianal crohn s disease clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are perianal crohn s disease trials in Japan?
Active perianal crohn s disease trials in Japan span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global perianal crohn s disease Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology